What's Going On With Capricor Therapeutics Stock Friday?
What's Going On With Capricor Therapeutics Stock Friday?
Capricor Therapeutics, Inc. (NASDAQ:CAPR) shares are trading higher on Friday. The company announced the long-term benefits of deramiocel for the treatment of duchenne muscular dystrophy (DMD).
週五，Capricor Therapeutics, Inc.（納斯達克股票代碼：CAPR）股價上漲。該公司宣佈了deramiocel在治療杜氏肌肉萎縮症（DMD）方面的長期益處。
What Happened: The biotechnology company said deramiocel increased cardiac function based on several different measures.
發生了什麼：這家生物技術公司表示，根據幾種不同的衡量標準，deramiocel可以增強心臟功能。
The study found improvements in left ventricular ejection fraction, left ventricular end systolic volume and left ventricular end diastolic volume. Capricor stated that these measures are considered highly applicable when projecting future outcomes.
該研究發現，左心室射血分數、左心室末期收縮壓容積和左心室末舒張容積都有所改善。Capricor表示，在預測未來結果時，這些措施被認爲非常適用。
The trial also demonstrated increased skeletal function, particularly increased performance of upper limb.
該試驗還顯示骨骼功能增強，尤其是上肢的表現得到提高。
The company based these positive findings off the ongoing HOPE-2 open label extension study. Capricor is expected to present these results at the Parent Project Muscular Dystrophy (PPMD) Annual Conference on Saturday.
該公司根據正在進行的 HOPE-2 開放標籤擴展研究得出這些積極的發現。預計Capricor將在週六的家長項目肌肉萎縮症（PPMD）年會上公佈這些結果。
Related Link: Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
相關鏈接：華爾街最準確的分析師對3只股息收益率超過3％的醫療保健股票發表了看法
CAPR Price Action: Capricor Therapeutics shares are trading 4.39% higher at $4.84 at the time of writing per data from Benzinga Pro.
CAPR價格走勢：根據Benzinga Pro的數據，在撰寫本文時，Capricor Therapeutics的股價上漲4.39％，至4.84美元。
Image: Shutterstock/ REDPIXEL.PL
圖片：Shutterstock/REDPIXEL.PL